nuviva semaglutide Wegovy® 0.25 mg / 0.5 mL Injection 4 Novo sues Lilly, alleging 'misleading'

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes

"After I had my kids, after I got a tad bit older, my body was missing something, no matter what I did," she said on the 3rd hour of TODAY

Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM

Glucagon-like Peptide-1 (GLP-1) Agonists Recent Developments In June 2026, Viking Therapeutics announced on June 24 the initiation of its Phase 1 clinical trial evaluating VK3019, an investigational dual amylin and calcitonin receptor agonist (DACRA)

This is due to underreporting of overweight and obesity diagnoses in the Danish registries, and the fact that GLP-1 receptor agonists were not approved for the treatment of obesity until December 2022

Cerebellum-dependent learning: the role of multiple plasticity mechanisms